Genetic testing and personalized ovarian cancer screening: a survey of public attitudes

about

Moving towards population-based genetic risk prediction for ovarian cancer.

P2860

Q40327531-6D81392E-2AC8-452D-9C8F-C15953AEA007

P2860

Genetic testing and personalized ovarian cancer screening: a survey of public attitudes

Item

http://www.wikidata.org/entity/Q36086513

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Genetic testing and personalized ovarian cancer screening: a survey of public attitudes

@ast

Genetic testing and personalized ovarian cancer screening: a survey of public attitudes

@en

type

Item

label

Genetic testing and personalized ovarian cancer screening: a survey of public attitudes

@ast

Genetic testing and personalized ovarian cancer screening: a survey of public attitudes

@en

prefLabel

Genetic testing and personalized ovarian cancer screening: a survey of public attitudes

@ast

Genetic testing and personalized ovarian cancer screening: a survey of public attitudes

@en

P1476

Genetic testing and personalized ovarian cancer screening: a survey of public attitudes

@en

P2093

Lucy Side

http://www.w3.org/2001/XMLSchema#string

PROMISE-2016 study team

http://www.w3.org/2001/XMLSchema#string

Sue Gessler

http://www.w3.org/2001/XMLSchema#string

Susanne F Meisel

http://www.w3.org/2001/XMLSchema#string

P2860

Users' motivations to purchase direct-to-consumer genome-wide testing: an exploratory study of personal stories

Effect of Screening on Ovarian Cancer Mortality

Germline mutations in RAD51D confer susceptibility to ovarian cancer

Mutations in BRIP1 confer high risk of ovarian cancer

Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene

Progress and challenges in screening for early detection of ovarian cancer.

Personal genomics and individual identities: motivations and moral imperatives of early users.

Cancer risk in mutation carriers of DNA-mismatch-repair genes.

Potential effect of the risk of ovarian cancer algorithm (ROCA) on the mortality outcome of the Prostate, Lung, Colorectal and Ovarian (PLCO) trial.

Population testing for cancer predisposing BRCA1/BRCA2 mutations in the Ashkenazi-Jewish community: a randomized controlled trial

P2888

s12905-016-0325-3

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12905-016-0325-3

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-07-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1033168096

http://www.w3.org/2001/XMLSchema#string

P698

27460568

http://www.w3.org/2001/XMLSchema#string

P921

ovarian cancer

P932

4962369

http://www.w3.org/2001/XMLSchema#string

Genetic testing and personalized ovarian cancer screening: a survey of public attitudes

about

P2860

P2860

Genetic testing and personalized ovarian cancer screening: a survey of public attitudes

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P6179

P698

P921

P932